Early stage breast cancer patients have a better chance of survival when they receive the full recommended dose of adjuvant chemotherapy. The treatment may be delayed or the dose reduced because certain patients may develop drug-related adverse side effects. However, data from a new study indicates that more than half of the women treated for early stage breast cancer do not receive the full recommended dose of chemotherapy.
Go to Previous Page
Go to Next Page